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The innate immune sensor RIG-I recognizes viral RNAwhile avoiding unwanted activation by self RNA. In this
issue of Immunity, Schuberth-Wagner et al. (2015) show that a histidine residue in the RNA binding pocket of
RIG-I sterically excludes the cap1 structure of self RNA, thereby preventing downstream activation.The innate immune sensors RIG-I and
MDA5 sense RNA virus genomes, leading
to activation of the transcription factor
IRF3 and induction of interferon-mediated
antiviral responses.Structural studies indi-
cate that RIG-I recognizes the 50 triphos-
phate terminus of double-stranded RNA
(dsRNA) (reviewed in Kolakofsky et al.,
2012), whereas MDA5 binds the internal
duplex structure (Wu et al., 2013). Similar
to viral RNAs, endogenous host RNAs
also contain a 50 triphosphate end. The
mechanisms by which sensors like RIG-I
and MDA5 can distinguish viral from self
RNA have been under active investigation
(Anchisi et al., 2015; Kato et al., 2011).
Accumulating evidence suggests that
enzymatic modification of host RNA con-
fers molecular signatures that mask an
otherwise stimulatory molecule (Hornung
et al., 2006; Pichlmair et al., 2006).
Eukaryotic mRNA is characterized by
a cap structure that consists of a 50
triphosphate linked to a methylated gua-
nosine at N7 (
m7G). This cap0 structure
is essential for translation initiation and
mRNA stability. The mRNA of higher eu-
karoytes is also modified by 20O-methyl-
ation at N1 (cap1) and N2 (cap2). Previous
studies implicated the cap0 structure of
RNA ligands as an inhibitory modification
to RIG-I activation. However, additional
work demonstrated that the in vitro
transcription protocols typically used
to generated these ligands can also
generate aberrant 50 triphosphate-con-
taining RNAs that activate RIG-I (Schlee
et al., 2009). A systematic characterization
of the relative contributions of host modifi-
cations to the stimulatory or inhibitory
properties of synthetic (not in vitro-tran-
scribed) dsRNA has not been carried out.
In this study, Schuberth-Wagner et al.
(2015) sought to characterize which of
these 50 mRNA modifications prevent
RIG-I activation. In lieu of in vitro transcrip-tion, they synthesized a series of well-
defined 24-mer RNA ligands containing a
50-triphosphate (ppp-RNA) and one or
more features of cap0, cap1, or cap2
RNAs. Single-stranded RNAs containing
these modifications were hybridized to a
complementary RNA to generate blunt-
ended dsRNA molecules. The identity and
purity of the capped RNAs were verified
bymass spectrometry. The various RNA li-
gandswere transfected intohumanperiph-
eral blood mononuclear cells (PBMCs) or
murine bone-marrow-derived dendritic
cells, and RIG-I activation was measured
by IFN-a production. The authors found
that a single 20O-methyl group at N1
(pppGmA, cap1 modification) completely
abolished RIG-I activation (Figure 1),
whereas the cap0 and cap2 modifications
only modestly reduced IFN-a induction.
To determine structural features of RIG-I
that confer protection from activation by
self RNAs, the authors mutated selected
amino acids in the RIG-I RNA binding
pocket. The RIG-I mutants were assayed
for activation by IP-10 induction in RIG-I-
deficient 293 cells. An unmodified ppp-
dsRNA unexpectedly showed higher acti-
vation in cells expressing RIG-I with a
mutation (H830A) as compared to wild-
type RIG-I. Because H830 is dispensable
for activation and has been shown to con-
tact the 20OH of N1 in activating ligands,
the authors hypothesized that RNA ligands
with a 20O-methyl modification at N1 might
be subject to steric exclusion in the binding
pocket, thereby precluding activation.
To address this, the authors compared
RIG-I(WT) and RIG-I(H830A) activation by
their panel of 50-modified 24-mer dsRNAs.
Whereas RIG-I(WT) was not activated by
ppp-dsRNAcontaininga20O-methylgroup
atN1 (pppGmA),RIG-I(H830A)wassuscep-
tible to activation by this ligand (Figure 1).
A similar ligand with a m7G cap (m7G-
pppGmA) also activated RIG-I(H830A).ImmuIn vitro binding studies using WT and
H830A RIG-I largely confirmed the acti-
vation phenotypes. Ligands bearing cap1
modifications (m7G-pppGmA) bound RIG-
I(H830A) but not RIG-I(WT). In the absence
of the m7G modification, binding of the N1-
modified pppGmA dsRNA to RIG-I(H830A)
was reduced but not abolished. The au-
thors hypothesize that this unexpected
result might be due to residual, non-
competitive binding. Together, the results
suggest that H830 sterically excludes
ppp-dsRNAbearing20O-methylationatN1.
Because H830 is strictly conserved
across evolution and prevented RIG-I acti-
vation by N1-2
0O-methylated ppp-dsRNA,
theauthorsproposed that selfRNAbearing
thisprotective20O-methylationmight exist.
They first showed that long-term expres-
sionofRIG-I(H830A) incells lackingendog-
enous RIG-I(WT) could eventually trigger
IP-10 production in the absence of an
exogenous activating ligand, suggesting
cellular accumulation of RNAs bearing
20O-methylation at N1. The authors then
immunoprecipitated cellular RNAs that
associated with a FLAG-tagged RIG-I
truncation containing the ppp-dsRNA
binding domain (RD domain). These puri-
fied RNAs activated RIG-I(H830A), but not
RIG-I(WT), further implicating theexistence
of self RNAs that are modified to avoid
RIG-I activation. Lastly, siRNA-mediated
silencing of the endogenous cap1 methyl-
transferase (hMTr1) resulted in IFN induc-
tion in the presence, but not absence, of
RIG-I. These results indicated that the
host uses cap1 modification to prevent
the formation of self RNAswith immunosti-
mulatory properties.
To explore the relevance of 20O-methyl-
ation at N1 in the context of self versus
non-self RNA, the authors turned to the
flaviviruses, which express a 20O-methyl-
transferase activity as part of the multi-
functional non-structural protein 5 (NS5).nity 43, July 21, 2015 ª2015 Elsevier Inc. 1
Figure 1. Schematic of RIG-I Exclusion of Self RNA
The RIG-I helicase andC-terminal regulatory domain (blue ring) recognize dsRNA (red helix) containing a 50
triphosphate. In the absence of 20O-methylation at N1, a common feature of many viral RNAs, the dsRNA
binds RIG-I to activate downstream responses. Self RNA (and some evasion-competent viral RNA, such
as flavivirus) contains a 20O-methyl group at N1, which is excluded from the RIG-I binding pocket by a high-
ly conserved H830 residue. With a H830A mutation, RIG-I is susceptible to activation by 20O-methylated
self RNAs. For simplicity, the m7G modification has been omitted from the illustration.
Immunity
PreviewsA yellow fever virus replicon (YFVR)
bearing a NS5 E218A mutation, which ab-
rogates 20O-methylation activity, was
used to determine whether the virus natu-
rally uses 20O-methylation to evade host
recognition by RIG-I. In RIG-I-replete
A549 cells, replication of the YFVR-
E218A genome was attenuated when
compared to YFVR-WT. By contrast,
IFN-deficient Vero cells replicated both
E218A and WT YFVR to similar levels.
Similar results were obtained with fully
infectious viruses. When RIG-I(WT) was
expressed in RIG-I-deficient cells, YFVR-
E218A stimulated higher amounts of IP-
10 production when compared to YFVR-
WT. By contrast, both YFVR-WT and
YFVR-E218A activated cells expressing
RIG-I(H830A) to similar levels. These data
indicate that YFV NS5 methyltransferase
marks theviralRNAwitha20O-methylation
that evades recognition and activation of
RIG-I(WT) but not RIG-I(H830A).2 Immunity 43, July 21, 2015 ª2015 ElsevierThe findings in this study potentially
resolve the issue of how RIG-I can distin-
guish viral from self RNA. By capitalizing
on a highly conserved H830 residue,
RIG-I sterically avoids host RNAs contain-
ing a cap1 modification (Figure 1). This
result highlights a new function for 20O-
methylation, a well-known but not neces-
sarily well-understood RNA modification.
Recent work has also indicated that 20O-
methylation of viral RNAs allows viruses
to evade host restriction by MDA5 and
IFIT family members (Daffis et al., 2010;
Zu¨st et al., 2011), suggesting an increas-
ingly critical role for this RNAmodification.
This study implicates the existence of
a pool of self RNAs that can serve as
endogenous ligands for RIG-I. The stimu-
latory activity of these RNAs could be
revealed only by removing their 50 modifi-
cations or by using cells expressing RIG-
I(H830A) mutant. The identity and nature
of theseactivating self RNAswasnot char-Inc.acterized in this study. Thus, it is intriguing
to speculate whether they are random and
varied, or whether they fall into a specific
class of RNAs that might have functional
consequences to the immune system or
the host cell in general. It will also be of
great interest to determine whether a
similar pool of self RNAs exists in vivo.
Another consideration stemming from
this study is the potential for customiz-
able RIG-I-based ligands. Whereas 20O-
methylation at N1 abolished RIG-I activa-
tion, 20O-methylation at N2 was still
partially activating, but not to the extent
of non-methylated ppp-dsRNA. Thus,
one can envision generating novel RIG-I
ligands with titratable activation profiles
depending on their modifications. More-
over, the finding that H830 in the dsRNA
binding pocket of RIG-I is critical for
excluding self RNAs suggests that the
RIG-I binding pocket might also be cus-
tomizable. Engineering customRIG-I mol-
ecules with tailor-made ligands could pro-
vide useful tools for additional research
into ‘‘self versus non-self’’ recognition,
and might also serve as a platform for
the development of novel therapeutics.
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